BCL2 and melanoma: Examinations revealed a pro-apoptotic effect, as evidenced by morphological changes in melanoma cells and supported by Western blot data showing the downregulation of anti-apoptotic Bcl-2 expression coupled with the upregulation of pro-apoptotic Bax [44].